Business Description
Mithra Pharmaceuticals SA
ISIN : BE0974283153
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | -0.02 | |||||
Debt-to-Equity | -23.8 | |||||
Debt-to-EBITDA | -157.4 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -1 | |||||
Beneish M-Score | -0.95 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -18.9 | |||||
3-Year EPS without NRI Growth Rate | -18.2 | |||||
3-Year FCF Growth Rate | -0.6 | |||||
3-Year Book Growth Rate | -47.7 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 24.8 | |||||
14-Day RSI | 26.93 | |||||
6-1 Month Momentum % | -13.25 | |||||
12-1 Month Momentum % | -91.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.27 | |||||
Days Inventory | 858.52 | |||||
Days Sales Outstanding | 65.7 | |||||
Days Payable | 603.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -12.9 | |||||
Shareholder Yield % | -9.36 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.54 | |||||
Operating Margin % | -62.11 | |||||
Net Margin % | -125.8 | |||||
FCF Margin % | -45.22 | |||||
ROE % | -387.23 | |||||
ROA % | -18.93 | |||||
ROIC % | -23.96 | |||||
3-Year ROIIC % | -376.41 | |||||
ROC (Joel Greenblatt) % | -12.85 | |||||
ROCE % | -4.51 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 2.4 | |||||
PS Ratio | 0.18 | |||||
EV-to-EBIT | -14.61 | |||||
EV-to-Forward-EBIT | 5.43 | |||||
EV-to-EBITDA | -150.38 | |||||
EV-to-Forward-EBITDA | 4.04 | |||||
EV-to-Revenue | 3.17 | |||||
EV-to-Forward-Revenue | 1.69 | |||||
EV-to-FCF | -7 | |||||
Earnings Yield (Greenblatt) % | -6.84 | |||||
FCF Yield % | -196.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mithra Pharmaceuticals SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 62.675 | ||
EPS (TTM) (€) | -1.41 | ||
Beta | -0.6 | ||
Volatility % | 72.11 | ||
14-Day RSI | 26.93 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 0.18 | ||
12-1 Month Momentum % | -91.18 | ||
52-Week Range (€) | 0.18 - 2.16 | ||
Shares Outstanding (Mil) | 66.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mithra Pharmaceuticals SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mithra Pharmaceuticals SA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mithra Pharmaceuticals SA Frequently Asked Questions
What is Mithra Pharmaceuticals SA(STU:1TM)'s stock price today?
When is next earnings date of Mithra Pharmaceuticals SA(STU:1TM)?
Does Mithra Pharmaceuticals SA(STU:1TM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |